Polarean Imaging (POLX LN)

Polarean Imaging is a medical imaging technology company focused on advancing its XENOVIEW MRI Platform, an FDA-approved functional lung imaging platform. The company develops and commercializes gas polarizer devices, ancillary instruments, and the hyperpolarized xenon MRI inhaled contrast agent, XENOVIEW, to enable direct, quantitative, regional assessment of lung ventilation using MRI. Polarean Imaging is headquartered in Durham, North Carolina, and was founded in 2012.